Delta and lambda viruses increase contagiousness and transmissibility and contribute to the severity of the COVID-19 disease. Molecular docking is frequently used for drug discovery as it can screen bioactive compounds and test their potential for specific targets. Herein, we screened bio-active compounds in methanol extracts of edible snails using the GC-MS method of which 13 compounds were selected for analysis of their anti-COVID-19 potency by docking methodagainst SARS-CoV-2 proteins (6WCF and 6Y84) in order to investigate their antiviral potency. In the present work, the top compound binding energy with the SARS CoV-2 (6WCF/6Y84) was bis(3-methylbut-3-en-1-yl) phthalate (-12.825 Kcl/mol) in binding with 6WCF, and a binding energy of -11.97 kcl/mol with 6Y84, while the standard drug (hydroxychloroquine) has a binding energy of -8.31 Kcal/mol with 6WCF and -8.59 Kcl/mol with 6Y84. To further evaluate the potential effects of these important bioactive compounds against SARS-CoV-2, more in vitro and in vivo experimental validation is required.